The Effects of Concomitant GLP-1 and Insulin in T2DM
the MPR take:
Based on study data published in the journal Diabetes Care, the administration of glucagon-like peptide (GLP-1) and insulin together has been shown to be more effective in improving endothelial dysfunction, inflammation, and oxidative stress in patients with type 2 diabetes compared to treatment with either alone.
OBJECTIVE: To test the hypothesis that the simultaneous administration of GLP-1 and insulin may increase their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes. RESEARCH DESIGN AND METHODS In two groups of persons with type 2 diabetes, two sets of experiments were ...
READ FULL ARTICLE From Diabetesjournals